Effect of citral on the cytotoxicity of doxorubicin in human B-lymphoma cells

References

• Chaouki W, Leger DY, Liagre B, et al. (2009). Citral inhibits cell proliferation and induces apoptosis and cell cycle arrest in MCF-7 cells. Fund Clin Pharmacol 23:549–56
   PubMed Web of Science ®Google Scholar
• Chen C, Edelstein LC, Gélinas C. (2000). The Rel/NF-κB family directly activates expression of the apoptosis inhibitor Bcl-x(L). Mol Cell Biol 20:2687–95
   PubMed Web of Science ®Google Scholar
• Chipuk JE, Green DR. (2008). How do Bcl-2 proteins induce mitochondrial outer membrane permeabilization? Trends Cell Biol 18:157–64
   PubMed Web of Science ®Google Scholar
• Chou T-C. (2010). Drug combination studies and their synergy quantification using the Chou–Talalay method. Cancer Res 70:440–6
   PubMed Web of Science ®Google Scholar
• Chougule MB, Patel A, Sachdeva P, et al. (2011). Enhanced anticancer activity of gemcitabine in combination with noscapine via antiangiogenic and apoptotic pathway against non-small cell lung cancer. PLoS One 6:e27394
   PubMed Web of Science ®Google Scholar
• Dudai N, Weinstein Y, Krup M, et al. (2005). Citral is a new inducer of caspase-3 in tumor cell lines. Planta Med 71:484–8
   PubMed Web of Science ®Google Scholar
• Edris AE. (2007). Pharmaceutical and therapeutic potentials of essential oils and their individual volatile constituents: A review. Phytother Res 21:308–23
   PubMed Web of Science ®Google Scholar
• Ferlay J, Soerjomataram I, Ervik M, et al. (2012). Cancer incidence and mortality worldwide [Online]. Available from: http://globocan.iarc.fr. [last accessed 28 Jan 2014]
   Google Scholar
• Fu L, Lin-Lee Y-C, Pham LV, et al. (2006). Constitutive NF-κB and NFAT activation leads to stimulation of the BLyS survival pathway in aggressive B-cell lymphomas. Blood 107:4540–8
   PubMed Web of Science ®Google Scholar
• Garg AK, Buchholz TA, Aggarwal BB. (2005). Chemosensitization and radiosensitization of tumors by plant polyphenols. Antioxid Redox Signal 7:1630–47
   PubMed Web of Science ®Google Scholar
• Hayes AJ, Markovic B. (2002). Toxicity of Australian essential oil Backhousia citriodora (Lemon myrtle). Part 1. Antimicrobial activity and in vitro cytotoxicity. Food Chem Toxicol 40:535–43
   PubMed Web of Science ®Google Scholar
• Hennessy BT, Hanrahan EO, Daly PA. (2004). Non-Hodgkin lymphoma: An update. Lancet Oncol 5:341–53
   PubMed Web of Science ®Google Scholar
• Jazirehi AR, Gan XH, Vos SD, et al. (2003). Rituximab (anti-CD20) selectively modifies Bcl-xl and apoptosis protease activating factor-1 (Apaf-1) expression and sensitizes human non-Hodgkin's lymphoma B cell lines to paclitaxel-induced apoptosis. Mol Cancer Ther 2:1183–93
   PubMed Web of Science ®Google Scholar
• Karin M, Cao Y, Greten FR, Li Z-W. (2002). NF-κB in cancer: From innocent bystander to major culprit. Nat Rev Cancer 2:301–10
   PubMed Web of Science ®Google Scholar
• Lee HJ, Jeong HS, Kim DJ, et al. (2008). Inhibitory effect of citral on NO production by suppression of iNOS expression and NF-κB activation in RAW264.7 Cells. Arch Pharm Res 31:342–9
   PubMed Web of Science ®Google Scholar
• Li Z-M, Jiang W-Q, Zhu Z-Y, et al. (2008). Synergistic cytotoxicity of Bcl-xl inhibitor gossypol and chemotherapeutic agents in non-Hodgkin's lymphoma cells. Cancer Biol Ther 7:51–60
   PubMed Web of Science ®Google Scholar
• Luo D, Cheng SC-S, Xie H, Xie Y. (2000). Effects of Bcl-2 and Bcl-xl protein levels on chemoresistance of hepatoblastoma HepG2 cell line. Biochem Cell Biol 78:119–26
   PubMed Web of Science ®Google Scholar
• Martinou JC, Youle RJ. (2011). Mitochondria in apoptosis: Bcl-2 family members and mitochondrial dynamics. Dev Cell 21:92–101
   PubMed Web of Science ®Google Scholar
• Meng Q-x, Roubin RH, Hanrahan JR. (2013). Ethnopharmacological and bioactivity guided investigation of five TCM anticancer herbs. J Ethnopharmacol 148:229–38
   PubMed Web of Science ®Google Scholar
• Nagata S, Hanayama R, Kawane K. (2010). Autoimmunity and the clearance of dead cells. Cell 140:619–30
   PubMed Web of Science ®Google Scholar
• Pihlasalo J, Klika KD, Murzin DY, Nieminen V. (2007). Conformational equilibria of citral. J Mol Struct (Theochem) 814:33–41
   Web of Science ®Google Scholar
• Ress NB, Hailey JR, Maronpot RR, et al. (2003). Toxicology and carcinogenesis studies of microencapsulated citral in rats and mice. Toxicol Sci 71:198–206
   PubMed Web of Science ®Google Scholar
• Saddiq AA, Khayyat SA. (2010). Chemical and antimicrobial studies of monoterpene: Citral. Pestic Biochem Phys 98:89–93
   Web of Science ®Google Scholar
• Sarkar FH, Li Y. (2006). Using chemopreventive agents to enhance the efficacy of cancer therapy. Cancer Res 66:3347–50
   PubMed Web of Science ®Google Scholar
• Siripong P, Yahuafai J, Shimizu K, et al. (2006). Antitumor activity of liposomal naphthoquinone esters isolated from Thai medicinal plant: Rhinacanthus nasutus Kurz. Biol Pharm Bull 29:2279–83
   PubMed Web of Science ®Google Scholar
• Soni H, Pandya G, Patel P, et al. (2011). Beneficial effects of carbon monoxide-releasing molecule-2 (CORM-2) on acute doxorubicin cardiotoxicity in mice: Role of oxidative stress and apoptosis. Toxicol Appl Pharm 253:70–80
   PubMed Web of Science ®Google Scholar
• Willis SN, Chen L, Dewson G, et al. (2005). Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xl, but not Bcl-2, until displaced by BH3-only proteins. Genes Dev 19:1294–305
   PubMed Web of Science ®Google Scholar
• Xia H, Liang W, Song Q, et al. (2013). The in vitro study of apoptosis in NB4 cell induced by citral. Cytotechnology 65:49–57
   PubMed Web of Science ®Google Scholar
• Yao Y, Marassi FM. (2009). Bax and Bak caught in the act. Mol Cell 36:353–4
   PubMed Web of Science ®Google Scholar
• Yeo AT, Porco JA, Gilmore TD. (2012). Bcl-xl, but not Bcl-2, can protect human B-lymphoma cell lines from parthenolide-induced apoptosis. Cancer Lett 318:53–60
   PubMed Web of Science ®Google Scholar
• Zhong Y. (2006). Non-Hodgkin's lymphoma: What primary care professionals need to know?. J Nurse Pract 2:309–15
   Google Scholar